Edwards Lifesciences' Centera valve CE Mark'd

|About: Edwards Lifesciences Corp (EW)|By:, SA News Editor

Edwards Lifesciences (NYSE:EW) announces that its self-expanding CENTERA heart valve, indicated for severe symptomatic aortic stenosis in patients at high risk of open-heart surgery, is now CE Mark certified.

The company says CENTERA, delivered via a low-profile 14-French motorized delivery system, can be repositioned and is retrievable.

The device is not yet available in the U.S.

Subscribe for full text news in your inbox